Loading...

RDY

Dr. Reddy's Laboratories Ltd. Sponsored ADR · NYSE

Performance

+3.7%

1W

+4.12%

1M

-5.95%

3M

+4.59%

6M

+3.51%

YTD

+27.18%

1Y

Profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Investment Analysis Report: RDY

Overview

In this investment analysis report, we will delve into the financial statements of RDY, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's Balance Sheets, Income Statements, and Cashflow Statements over the past three years to gain insights into its valuation...

See more ...

Technical Analysis of RDY 2024-05-31

Overview:

In analyzing the technical indicators for RDY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the cl...
See more ...

Recent News & Updates